Category: Major Meetings

All Podcast Categories
S4-24.4 - INCBCN Day 2 Summary

S4-24.4 – INCBCN Day 2 Summary

Surfing NASH reviews the recently concluded 2023 Innovations in NAFLD Care Workshop with conference founders and directors, Jeff Lazarus and Jörn Schattenberg. This conversation looks into the second day of the conference and the impact that the FDA ADCOM on obeticholic acid has on all of these issues discussed.

S4-24.3 - Focus on Preventative Hepatology

S4-24.3 – Focus on Preventative Hepatology

Surfing NASH reviews the recently concluded 2023 Innovations in NAFLD Care Workshop with conference founders and directors, Jeff Lazarus and Jörn Schattenberg. This conversation takes a deeper dive into what constitutes ‘preventative hepatology.’ The group teases out multiple concepts of what this could or should look like.

S4-24.2 - INCBCN Review: NAFLD and Social Drinking

S4-24.2 – INCBCN Review: NAFLD and Social Drinking

Surfing NASH reviews the recently concluded 2023 Innovations in NAFLD Care Workshop with conference founders and directors, Jeff Lazarus and Jörn Schattenberg. This conversation considers alcohol consumption and its impact on NAFLD. Additionally, the group discusses applying FibroScan in different patient settings.

S4-24.1 - INCBCN Review: NASH-NITs Real-World-Evidence Summit

S4-24.1 – INCBCN Review: NASH-NITs Real-World-Evidence Summit

The opening conversation sets the stage for the 2023 Innovations in NAFLD Care Workshop held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and Jörn Schattenberg discuss this year’s goals of the event and facilitating the hands-on NASH-NITs Real-World-Evidence Summit.

S4-22 - PART 1: FDA ADCOM Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis Due to NASH

S4-22 – PART 1: FDA ADCOM Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis Due to NASH

Donna Cryer joins Jörn Schattenberg and Roger Green for a session which draws from raw reflections on the recent FDA Advisory Committee meeting and its outcome for obeticholic acid. The group remains focused on a critical message that looks down the path forward for the liver community and meeting patient needs. Stay tuned for more coverage as SurfingNASH continues to meet with other KOLs and stakeholders to discuss the event and its implications.

S4-21.5 - From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease

S4-21.5 – From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease

Roughly 5,000 liver community stakeholders gathered in London for the 2022 International Liver Congress (#ILC2022,) the first major hepatology Congress to be held in person since the start of the pandemic (smaller, but very valuable, meetings like NASH-TAG, LiverCONNECT and Paris NASH have taken place with an in-person component, but the International Liver Congress and The Liver Meeting have not).

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.